Brian A Gordon, Ph.D

2010- Radiology Washington University, Saint Louis, St. Louis, MO 
Aging, working memory, exercise
"Brian Gordon Washington University"

I obtained my PhD in Psychology at the University of Illinois in Urbana-Champaign. My PhD advisors were Drs. Monica Fabiani and Gabrielle Gratton. After completing my PhD I moved to a postdoctoral training position in the department of Psychological & Brain Sciences at Washington University in St. Louis. I was mentored in this position by Drs. Denise Head, David Balota, and Jeff Zacks. After completing my postdoc I took up a faculty position in the Department of Radiology at Washington University. My primary faculty mentor in the medical school is Dr. Tammie Benzinger. As part of my K01 award I am additionally mentored by Dr. Randall Bateman and Dr. John Morris.

Cross-listing: Neurotree


Sign in to add mentor
Gabriele Gratton grad student UIUC (Neurotree)
Monica Fabiani grad student 2010 UIUC
 (Aging and inhibitory control.)
David A. Balota post-doc 2010-2014 Washington University (Neurotree)
Denise P. Head post-doc 2010-2014 MIT, Washington University in St. Louis (Neurotree)
Jeffrey M. Zacks post-doc 2010-2014 Washington University (Neurotree)


Sign in to add collaborator
John C. Morris collaborator 2010- Washington University (Neurotree)
Tammie Benzinger collaborator 2013- Washington University (Neurotree)
Randall Bateman collaborator 2015- Washington University (Neurotree)
Arthur F. Kramer collaborator 2003-2010 UIUC (Neurotree)
Bradley P. Sutton collaborator 2003-2010 UIUC (BME Tree)
BETA: Related publications


You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect.

Dincer A, Chen CD, McKay NS, et al. (2022) APOE ε4 genotype, amyloid-β, and sex interact to predict tau in regions of high APOE mRNA expression. Science Translational Medicine. 14: eabl7646
Wang G, Li Y, Xiong C, et al. (2022) Evaluation of dose-dependent treatment effects after mid-trial dose escalation in biomarker, clinical, and cognitive outcomes for gantenerumab or solanezumab in dominantly inherited Alzheimer's disease. Alzheimer's & Dementia (Amsterdam, Netherlands). 14: e12367
Warren-Gash C, Cadogan SL, Nicholas JM, et al. (2022) Herpes simplex virus and rates of cognitive decline or whole brain atrophy in the Dominantly Inherited Alzheimer Network. Annals of Clinical and Translational Neurology
Hartz SM, Mozersky J, Schindler SE, et al. (2022) A flexible modeling approach for biomarker-based computation of absolute risk of Alzheimer's disease dementia. Alzheimer's & Dementia : the Journal of the Alzheimer's Association
Joseph-Mathurin N, Llibre-Guerra JJ, Li Y, et al. (2022) Amyloid-related imaging abnormalities in the DIAN-TU-001 trial of gantenerumab and solanezumab: lessons from a trial in dominantly inherited Alzheimer disease. Annals of Neurology
Nicosia J, Aschenbrenner AJ, Balota DA, et al. (2022) Unsupervised high-frequency smartphone-based cognitive assessments are reliable, valid, and feasible in older adults at risk for Alzheimer's disease. Journal of the International Neuropsychological Society : Jins. 1-13
Flores S, Chen CD, Su Y, et al. (2022) Investigating Tau and Amyloid Tracer Skull Binding in Studies of Alzheimer disease. Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
Luo J, Agboola F, Grant E, et al. (2022) Accelerated longitudinal changes and ordering of Alzheimer disease biomarkers across the adult lifespan. Brain : a Journal of Neurology
Strain JF, Brier MR, Tanenbaum A, et al. (2022) Covariance-based vs. Correlation-based Functional Connectivity Dissociates Healthy Aging from Alzheimer Disease. Neuroimage. 119511
Strikwerda-Brown C, Hobbs DA, Gonneaud J, et al. (2022) Association of Elevated Amyloid and Tau Positron Emission Tomography Signal With Near-Term Development of Alzheimer Disease Symptoms in Older Adults Without Cognitive Impairment. Jama Neurology
See more...